• Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Medical Equipment

Pharmaxis Ltd

+ Add to Watchlist

PXSLY:US

0.9010 USD 0.0555 5.80%

As of 20:10:00 ET on 06/20/2014.

Snapshot for Pharmaxis Ltd (PXSLY)

Open: 0.9010 Day's Range: 0.9010 - 0.9010 Volume: 1,000
Previous Close: 0.9565 52wk Range: 0.8760 - 2.1700 1-Yr Rtn: -

Stock Chart for PXSLY

No chart data available.
  • PXSLY:US 0.9010
  • 1D
  • 1M
  • 1Y
0.9565
Interactive PXSLY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PXSLY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 18.60
Shares Outstanding (M) 20.64
30 Day Average Volume 34
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/20/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PXSLY

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PXSLY

Pharmaxis Ltd. is a pharmaceutical company which develops therapeutic products for the human chronic respiratory and autoimmune diseases. The Company operates in Australia.

Gary Jonathan PhillipsChief Executive OfficerDavid Morris McGarveyCFO/Secretary
Howard George FoxChief Medical OfficerBrett CharltonDirector:Medical/Co-Founder
More Company Profile & Key Executives for PXSLY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil